Robust single-agent efficacies have also been seen in medulloblastomas, where nearly one-third of cases are associated with constitutive activation of the Gli1 transcription factor through similar oncogenic mutations in the Hedgehog pathway [47]. The gene discussed is GLI1; the disease is medulloblastoma.